Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems-Reference-Cited by-同舟云学术

Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems

Published:2022-12 Issue: Volume:66 Page:101638
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Yang Bin,Gelfanov Vasily M.,El Kimberley,Chen Alex,Rohlfs Rebecca,DuBois Barent,Kruse Hansen Ann Maria,Perez-Tilve Diego,Knerr Patrick J.,D'Alessio David,Campbell Jonathan E.,Douros Jonathan D.,Finan Brian

Funder

Novo Nordisk

University of Cincinnati

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference50 articles.

1. Inhibition of gastric inhibitory polypeptide signaling prevents obesity;Miyawaki;Nat Med,2002

2. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance;Ayala;Endocrinology,2010

3. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure;Hansotia;J Clin Invest,2007

4. The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling;Zhang;Cell Metabol,2021

5. Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the structure and activation mechanism of some class B1 GPCR family members;Molecular Biology Reports;2024-09-06

2. The unexpected role of GIP in transforming obesity treatment;Trends in Endocrinology & Metabolism;2024-08

3. Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity;Expert Opinion on Investigational Drugs;2024-07-17

4. Transforming obesity: The advancement of multi-receptor drugs;Cell;2024-07

5. Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge;British Journal of Pharmacology;2024-07